SV Health Investors — 2013 Investments

2 investments dated 2013 · listed companies and verified rows first · show all

Avitideavitide.com inSeries A · Mar 2013 · $1Macquired by Repligen

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.

BiotechHardwareMedical DevicesLebanon, US

Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)

Co-investorsOrbiMed Borealis Ventures Mithril Capital Management Polaris Partners Sands Capital Ventures SV Life Sciences

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Soffio Medical

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.